Summary of Study ST000898

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000624. The data can be accessed directly via it's Project DOI: 10.21228/M8109M This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST000898
Study TitleTAp73 is a marker of glutamine addiction in medulloblastoma
Study TypesiRNA constructs targeting p73 (ID: 2671-AMBION) and a non-targeting control siRNA (scramble) were transfected with 10 pM siRNA with lipofectamine 3000 according to the supplier’s protocol for 48 hours
Study SummaryMetabolically-targeted therapies hold the promise of offering an effective and less toxic treatment for tumours including medulloblastoma, the most common malignant brain tumour of childhood. Current treatment relies on the sensitivity of these tumours to DNA damage that was discovered more than 50 years ago. Finding new tumour-specific susceptibilities to complement sensitivity to DNA damage is key to developing new more effective adjuvant therapies. The specific metabolic program of tumours is an attractive vulnerability, as restriction diet are low cost and easy to implement. Here, we present compelling pre-clinical evidence that glutamine restriction diet can be used as an adjuvant treatment for p73-expressing medulloblastoma.
Institute
Queen Mary University of London
DepartmentBlizard Institute
LaboratoryCentre for Genomics and Child Health
Last NameMarino
First NameSilvia
Address4 Newark Street, E1 2AT, London
Emails.marino@qmul.ac.uk
Phone+44 20 7882 2360
Submit Date2017-08-24
Num Groups2
Total Subjects18
Study CommentsWe include 3 biological replicate with 3 technical replicates for each condition.
Raw Data AvailableYes
Analysis Type DetailLC-MS
Release Date2017-11-20
Release Version1
Silvia Marino Silvia Marino
https://dx.doi.org/10.21228/M8109M
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id treatment
SA052758Control_7.1Control
SA052759Control_7.2Control
SA052760Control_6.3Control
SA052761Control_6.2Control
SA052762Control_6.1Control
SA052763Control_8.1Control
SA052764Control_8.3Control
SA052765Control_9.3Control
SA052766Control_1.1Control
SA052767Control_9.2Control
SA052768Control_9.1Control
SA052769Control_5.3Control
SA052770Control_8.2Control
SA052771Control_7.3Control
SA052772Control_2.3Control
SA052773Control_3.1Control
SA052774Control_2.2Control
SA052775Control_2.1Control
SA052776Control_1.2Control
SA052777Control_5.2Control
SA052778Control_3.2Control
SA052779Control_1.3Control
SA052780Control_4.3Control
SA052781Control_3.3Control
SA052782Control_4.2Control
SA052783Control_5.1Control
SA052784Control_4.1Control
SA052785Si p73_7.1Si p73
SA052786Si p73_7.2Si p73
SA052787Si p73_6.1Si p73
SA052788Si p73_6.3Si p73
SA052789Si p73_7.3Si p73
SA052790Si p73_6.2Si p73
SA052791Si p73_9.1Si p73
SA052792Si p73_9.3Si p73
SA052793Si p73_5.3Si p73
SA052794Si p73_9.2Si p73
SA052795Si p73_8.3Si p73
SA052796Si p73_8.2Si p73
SA052797Si p73_8.1Si p73
SA052798Si p73_1.1Si p73
SA052799Si p73_2.2Si p73
SA052800Si p73_2.3Si p73
SA052801Si p73_2.1Si p73
SA052802Si p73_1.3Si p73
SA052803Si p73_1.2Si p73
SA052804Si p73_3.1Si p73
SA052805Si p73_3.2Si p73
SA052806Si p73_4.3Si p73
SA052807Si p73_5.1Si p73
SA052808Si p73_4.2Si p73
SA052809Si p73_4.1Si p73
SA052810Si p73_3.3Si p73
SA052811Si p73_5.2Si p73
Showing results 1 to 54 of 54
  logo